Esperion Therapeutics@KalaGhazi
Esperion Therapeutics
Big drop yesterday.
Will it rally or back down again???
−2.37USD
−233.659MUSD
75.475MUSD
112.754M
About Esperion Therapeutics, Inc.
Sector
CEO
Sheldon L. Koenig
Headquarters
Ann Arbor
Website
Employees (FY)
199
Founded
1998
ISIN
US29664W1053
Esperion Therapeutics, Inc. is a pharmaceutical company. It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.
ESPR (Esperion Therapeutics) short positionESPR (Esperion Therapeutics) short position
Entry level: $7.93
Take profit: $6.82
Stop loss: $8.48
Preparing for Earnings Season: ESPRStocks that are reporting earnings in 3 to 4 weeks can be monitored for pre-earnings runs.
ESPR had momentum runs recently, as marked by the candlestick patterns within the green rectangles in this chart. A shift of sentiment can be seen in the bottoming pattern with Accumulation/Distribution indi
Esperion Therapeutics On the above 3-week chart price action for Esperion Therapeutics has collapsed over 90% since the sell signal in early 2018. Now is an excellent moment to be dollar cost averaging into a long position. Why?
1) A fantastic ‘buy’ signal. Remember this is a 3-week chart. Very powerful on this scale,
ESPERION (HOW TO MAKE SOME MONEY)Target price is 11 $
That's enough:) If u have any questions make a comment below
short sellers will hurt bad in this one!Market Cap: 370 M
Shares Outstanding: 28.2M
Average Trading Volume (10 days): 451K
Shares Short: 28 M
Short Interest(%): 31.4%
Days to cover: 15.4
Change in Short Interest: -35
Ownership Breakdown:
Institutions: 93.1%
General Public:
Hedge Funds: 5.6%
Individual insiders: 1.3%
Sum: 100%
Option p
$ESPR Short squeeze - 1 D Candle I think ESPR could start to get interested in this level .
- After a long decline from the peak ($ 40) this year, on 27/1/2021, we are now witnessing a consolidation in the price level.
- I do not look at fundamental information, only technical data .
Indicators :
* EMA21 is the purple line
* EMA
ESPRMID-TERM: Holding support with classic bullish divergence. High short float. (not financial advice)
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
